Stay updated with breaking news from Us Compounding Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
USA Compounding Pharmacies MarketThe USA compounding pharmacies market is anticipated to reach a valuation of US$ 11,099.0 million in 2023, driven by customization of various kinds of drugs. The trend is expected to create new opportunities for the global market, leading to a projected CAGR of 7.8% between 2023 and...
DSMB met to evaluate interim clinical and safety data and clears Phase 2/3 study to continue...
Adamis Pharmaceuticals’ Clinical Study Assessing Tempol for the Treatment of COVID-19 Surpasses Enrollment Expectations - read this article along with other careers information, tips and advice on BioSpace
SAN DIEGO, Feb. 07, 2022 -- Adamis Pharmaceuticals Corporation today announced the enrollment and dosing of more than 100 subjects in the Company’s ongoing Phase 2/3 study of Tempol for... | February 7, 2022
SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the submission of a Fast Track Application...